Yahoo
HKSE - Delayed Quote HKD

Fangzhou Inc. (6086.HK)

1.005 -0.040 (-3.83%)
At close: November 6 at 4:08:50 PM GMT+8
Chart Range Bar
Loading chart for 6086.HK
  • Previous Close 1.045
  • Open 1.010
  • Bid 1.000 x --
  • Ask 1.030 x --
  • Day's Range 0.990 - 1.040
  • 52 Week Range 0.625 - 4.330
  • Volume 183,000
  • Avg. Volume 293,714
  • Market Cap (intraday) 1.392B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 100.50
  • EPS (TTM) 0.010
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 6.03
  • Moby Rating Neutral

Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases. It also engages in the sales of pharmaceutical and healthcare products through online retail pharmacy service platform, third-party platforms, and offline retail pharmacies; and online consultation, e-prescription, physician consultation, physical examination, and surgery service, as well as wholesale of pharmaceutical products. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.

Jianke.com

514

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

6086.HK
55.73%
HANG SENG INDEX (^HSI)
4.48%

1-Year Return

6086.HK
69.82%
HANG SENG INDEX (^HSI)
7.57%

3-Year Return

6086.HK
78.53%
HANG SENG INDEX (^HSI)
36.26%

5-Year Return

6086.HK
78.53%
HANG SENG INDEX (^HSI)
1.56%

Analyst Insights

View More

Analyst Price Targets

6.03
6.03 Average
1.005 Current
6.03 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.21%

  • Return on Assets (ttm)

    0.59%

  • Return on Equity (ttm)

    3.70%

  • Revenue (ttm)

    3.86B

  • Net Income Avi to Common (ttm)

    8.26M

  • Diluted EPS (ttm)

    0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    418.73M

  • Total Debt/Equity (mrq)

    7.72%

  • Levered Free Cash Flow (ttm)

    11.43M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: